Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, open label clinical trial is to determine if oral miltefosine
is a safe and effective alternative, compared with parenteral meglumine antimoniate for the
treatment of pediatric Cutaneous caused by L. Viannia species in Colombia.
Phase:
Phase 3
Details
Lead Sponsor:
Centro Internacional de Entrenamiento e Investigaciones Médicas
Collaborators:
INS Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) Instituto Nacional de Dermatología Centro dermatológico Federico Lleras Acosta